Timur Dogan
Direttore Tecnico/Scientifico/R&S presso CARDIO DIAGNOSTICS HOLDINGS, INC.
Patrimonio netto: 92 665 $ in data 30/04/2024
Profilo
Timur Dogan is currently the Chief Technology Officer at Cardio Diagnostics Holdings, Inc. He previously held the same position at Cardio Diagnostics, Inc. Dr. Dogan obtained his undergraduate, graduate, and doctorate degrees from the University of Iowa.
Partecipazioni note in società pubbliche
Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
---|---|---|---|---|
01/04/2024 | 128 345 ( 0.59% ) | 92 665 $ | 30/04/2024 |
Posizioni attive di Timur Dogan
Società | Posizione | Inizio |
---|---|---|
CARDIO DIAGNOSTICS HOLDINGS, INC. | Direttore Tecnico/Scientifico/R&S | 25/10/2022 |
Precedenti posizioni note di Timur Dogan
Società | Posizione | Fine |
---|---|---|
Cardio Diagnostics, Inc.
Cardio Diagnostics, Inc. Medical/Nursing ServicesHealth Services Part of Cardio Diagnostics Holdings, Inc., Cardio Diagnostics, Inc. is a biotechnology company based in Chicago, IL. The company is focused on making cardiovascular disease prevention and early detection more accessible, personalized, and precise. The company's flagship solution, the Cardio Diagnostics Epi+Gen CHD™ test, helps clinicians better assess each patient's unique risk profile for disease. The company's vision is to transform medical care for cardiovascular disease from reactive to proactive. Cardio Diagnostics was founded in 2017 by Meeshanthini Dogan and Robert Philibert, with Meeshanthini Dogan serving as CEO since then. Cardio Diagnostics was acquired by Mana Capital Acquisition Corp. on October 25, 2022 for $61.51 million. | Direttore Tecnico/Scientifico/R&S | - |
Formazione di Timur Dogan
University of Iowa | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 2 |
---|---|
Cardio Diagnostics Holdings, Inc. | |
Cardio Diagnostics, Inc.
Cardio Diagnostics, Inc. Medical/Nursing ServicesHealth Services Part of Cardio Diagnostics Holdings, Inc., Cardio Diagnostics, Inc. is a biotechnology company based in Chicago, IL. The company is focused on making cardiovascular disease prevention and early detection more accessible, personalized, and precise. The company's flagship solution, the Cardio Diagnostics Epi+Gen CHD™ test, helps clinicians better assess each patient's unique risk profile for disease. The company's vision is to transform medical care for cardiovascular disease from reactive to proactive. Cardio Diagnostics was founded in 2017 by Meeshanthini Dogan and Robert Philibert, with Meeshanthini Dogan serving as CEO since then. Cardio Diagnostics was acquired by Mana Capital Acquisition Corp. on October 25, 2022 for $61.51 million. | Health Services |
- Borsa valori
- Insiders
- Timur Dogan